Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGENOMICS INC Director's Dealing 2014

Oct 14, 2014

32227_dirs_2014-10-14_ca6032e1-caac-4c97-9616-7a13a46955a8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2014-10-13

Reporting Person: SHOVLIN ROBERT J. (Chief Operating Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-10-13 Stock Option (Right to Buy) $4.79 A 300000 Acquired 2019-10-13 Common Stock (0) Direct

Footnotes

F1: On October 13, 2014 Mr. Shovlin was granted an option to purchase 300,000 shares. The options have time based vesting. On the first anniversary of the option grant date 75,000 shares vest. Then beginning on the thirteenth (13th) month through the fourth anniversary of the option grant date 6,250 shares will vest on a monthly basis.